azilsartan angiotensin receptor antagonist
|
||||||||||||||
|
|
|
|
||||||||||||
|
|
||||||||||||||
Stockphotos.ro (c) 2026. All stock photos are provided by Dreamstime and are copyrighted by their respective owners.
azilsartan angiotensin receptor antagonist |
||||||||||||||||||||||||||||||||||||||||
| navigate by keyword : 1it 2the adults adverse angiotensin antagonist azilsartan brand chlortalidone combination common developed diarrhea drug edarbi edarbycl edarbyclor form hypertension marketed medoxomil name prodrug reaction receptor sold tablet takeda treatment used |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| Azilsartan is an angiotensin II receptor antagonist used in the treatment of hypertension, developed by Takeda. It is marketed in tablet form under the brand name Edarbi as the prodrug azilsartan medoxomil. The most common adverse reaction in adults is diarrhea.[1]It is also sold as a combination drug with chlortalidone under the brand name Edarbyclor |
||||||||||||||||||||||||||||||||||||||||
|
Stockphotos.ro (c) 2026. All stock photos are provided by Dreamstime and are copyrighted by their respective owners. |
||||||||||||||||||||||||||||||||||||||||